A University of Otago bioethicist has added his voice to a global plea for a moratorium on heritable genome editing from a group of international scientists and ethicists in the wake of the recent Chinese experiment aiming to produce HIV immune children.
In an article in the latest issue of international scientific journal Nature, Professor Jing-Bao Nie together with another 16 academics from seven countries, call for a global moratorium on all clinical uses of human germline editing to make genetically modified children.
They would like an international governance framework – in which nations voluntarily commit to not approve any use of clinical germline editing unless certain conditions are met – to be created potentially for a five-year period.
Professor Nie says the scientific scandal of the experiment that led to the world’s first genetically modified babies raises many intriguing ethical, social and transcultural / transglobal issues. His main personal concerns include what he describes as the “inadequacy” of the Chinese and international responses to the experiment.
“The Chinese authorities have conducted a preliminary investigation into the scientist’s genetic misadventure and issued a draft new regulation on the related biotechnologies. These are welcome moves. Yet, by putting blame completely on the rogue scientist individually, the institutional failings are overlooked,” Professor Nie explains.
“In the international discourse, partly due to the mentality of dichotomising China and the West, a tendency exists to characterise the scandal as just a Chinese problem. As a result, the global context of the experiment and Chinese science schemes have been far from sufficiently examined.”
The group of 17 scientists and bioethicists say it is imperative that extensive public discussions about the technical, scientific, medical, societal, ethical and moral issues must be considered before germline editing is permitted. A moratorium would provide time to establish broad societal consensus and an international framework.
“For germline editing to even be considered for a clinical application, its safety and efficacy must be sufficient – taking into account the unmet medical need, the risks and potential benefits and the existence of alternative approaches,” the opinion article states.
Although techniques have improved in recent years, germline editing is not yet safe or effective enough to justify any use in the clinic with the risk of failing to make the desired change or of introducing unintended mutations still unacceptably high, the scientists and ethicists say.
“No clinical application of germline editing should be considered unless its long-term biological consequences are sufficiently understood – both for individuals and for the human species.”
The proposed moratorium does not however, apply to germline editing for research uses or in human somatic (non-reproductive) cells to treat diseases.
Professor Nie considers it significant that current presidents of the UK Royal Society, the US National Academy of Medicine and the Director and Associate Director of the US National Institute of Health have expressed their strong support for such a proposed global moratorium in two correspondences published in the same issue of Nature. The editorial in the issue also argues that the right decision can be reached “only through engaging more communities in the debate”.
“The most challenging questions are whether international organisations and different countries will adopt a moratorium and if yes, whether it will be effective at all,” Professor Nie says.
Learn more: Otago bioethicist adds voice to global plea for moratorium on heritable genome editing
The Latest on: Heritable genome editing
[google_news title=”” keyword=”heritable genome editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Heritable genome editing
- Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaborationon April 25, 2024 at 8:00 am
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
- Advancing crop breeding through targeted genome modificationon April 25, 2024 at 6:36 am
Modern crop breeding is entering a new era of genome design, led by genome editing technologies as mainstream tools for targeted genome modification. In a review published in Nature Reviews Genetics, ...
- AI-designed gene editing tools successfully modify human DNAon April 24, 2024 at 5:51 am
Medically, AI is helping us with everything from identifying abnormal heart rhythms before they happen to spotting skin cancer. But do we really need it to get involved with our genome? Protein-design ...
- Insights in Genome Editing in Cancer and Immunology 2024on April 24, 2024 at 12:21 am
We are now entering the third decade of the 21st Century, and, especially in the last years, the achievements made by scientists have been exceptional, leading to major advancements in the ...
- GU Medical Center Distinguished Scientist Seminar Series Illuminates Uses of Gene Editing in Cancer Researchon April 23, 2024 at 5:00 pm
A researcher highlighted gene editing and its therapeutic applications in a talk April 18. Raj Chari, director of the Genome Modification Core Laboratory at the Frederick National Laboratory for ...
- Profluent Successfully Edits Human Genome with OpenCRISPR-1, the World’s First AI-Created and Open-Source Gene Editoron April 22, 2024 at 9:30 am
With this launch, Profluent demonstrates the first successful precision editing of the human genome with customizable gene editors designed from scratch with AI. OpenCRISPR-1 is an AI-created gene ...
- Scientist jailed for gene-editing babies is working back in a labon April 1, 2024 at 7:11 am
Dr He Jiankui announced he had resumed research on human embryo genome editing in an interview with Mainichi Shimbun, a Japanese newspaper, but said he will comply with the rules set – and has ...
- Controversial Scientist Back at Work After Jail Time for Creating Genetically Modified Babieson March 31, 2024 at 5:00 pm
A Chinese scientist once jailed for helping to create the world’s first genome-edited babies seems to have not missed a beat. In a recent interview, He Jiankui revealed that he is once again ...
- Breaking ground in genome-editing technologyon March 27, 2024 at 5:01 pm
Genome editing technology that can change these chromosomes and genes has developed rapidly. From drug development and gene therapy, improvements to crops and livestock, to creating useful ...
- The first pig kidney has been transplanted into a living person. But we’re still a long way from solving organ shortageson March 27, 2024 at 12:08 pm
CRISPR gene editing takes advantage of a system ... In Australia, intentionally creating heritable alterations to the human genome is a criminal offence carrying 15 years’ imprisonment.
via Bing News